Our health service is in need of urgent reform, writes health secretary Wes Streeting – and it must embrace innovations if we want to turn the tide on cancer ...

A doctor shares exactly why attending your screenings is so important, including for younger people, this World Cancer Day.

A major trial aiming to transform breast cancer screening with artificial intelligence (AI) has been launched, with almost 700,000 women expected to take part, the Government has announced. It is ...

A trial using artificial intelligence (AI) in breast cancer screening could lead to a dramatic rise in the number of patients ...

Cost-effectiveness watchdog NICE has recommended routine NHS use of two new therapies for women with advanced breast cancer – Gilead's Trodelvy and Novartis' Piqray – in England.

Objective To use newly available self-assigned ethnicity information to investigate variation in breast cancer screening uptake for women from the 16 specific ethnic groups within the broad Asian, ...

Why are women screened for breast cancer while men are ignored? The old arguments no longer stack up, say experts Soho House founder Nick Jones has called for a national screening programme for ...

Prostate cancer is often seen as an unavoidable part of ageing, especially among men, but there are many myths that can create confusion.

Remember, it is your screening test, and you are in control,' GP Dr Amir Khan said. The NHS aims to eliminate cervical cancer by 2040, with the use of cervical screening and the HPV vaccine.

Following entry into a commercial agreement with Bayer, NHS England is the first healthcare ... for a diagnostic test for HER2-ultralow breast cancer, now on the label of AstraZeneca and Daiichi ...

TUESDAY commemorates World Cancer Awareness Day. This year’s theme is United by Unique which is a patient-centric initiative to improve understanding that underlying every cancer diagnosis is a unique ...

Bishal Gyawali, MD, PhD, and Sharon Batt, PhD, explore why overall survival continues to be the most patient-centric marker of clinical benefit.